KARLENE BOOZER: Open Payments
NPI 1417902917 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 8 payments from 6 companies in 2025. Trend: 2023 $596 · 2024 $464 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| ABBVIE INC. | 2 | $35 |
| Celgene Corporation | 1 | $19 |
| Kite Pharma, Inc. | 1 | $19 |
| Deciphera Pharmaceuticals Inc. | 1 | $18 |
| ARRAY BIOPHARMA INC | 1 | $17 |
Products named: Fabhalta, REBLOZYL, Yescarta, QINLOCK, IMBRUVICA, EPKINLY, BRAFTOVI.
Industry payments across AL — which companies pay providers there.
